https://www.selleckchem.com/pr....oducts/zinc05007751.
Our study aims at assessing the pre-clinical impact of the synergistic mechanism of Daptomycin (DAP) and Ceftaroline (CFT) on patients with Methicillin-Resistant Staphylococcus aureus Bacteremia infections (MRSA. A systematic overview was conducted by searching PubMed, Oxford academic, and Cochrane library up to June 2020. All English- language clinical trials, in vitro studies, and case reports related to the synergistic drug therapy for MRSAB. In the case of MRSAB infections, we examined two different in vitro studies that show
Aimer
Commentaire
Partagez
